E-drug: NEW: Therapeutics Letter 39 now on the web!
---------------------------------------------
I would like to bring to your attention the January/February 2001 issue
(#39) of the Therapeutics Letter: Selective COX-2 inhibitors: Are they safer
NSAIDs? that is now available on the Therapeutics Initiative web-site at
http://www.ti.ubc.ca/pages/letter39.htm
I invite you to drop by and have a look at this Letter. Please feel free to
forward this message to any of your friends or colleagues that might be
interested in this topic.
We would appreciate receiving your comments on this Therapeutics
Letter and its possible implications in clinical practice.
Best regards,
Ciprian D Jauca
Program Coordinator
Therapeutics Initiative - Evidence Based Drug Therapy
University of British Columbia
Canada
E-mail: jauca@ti.ubc.ca
Phone: +1 (604) 822-0700
GSM Mobile Phone: +1 (604) 722-2075
Fax: +1 (604) 822-0701
Web: http://www.ti.ubc.ca
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.